Log In
BCIQ
Print this Print this
 

Apomorphine patch

  Manage Alerts
Collapse Summary General Information
Company Nitto Denko Corp.
DescriptionApomorphine skin patch using PassPort system
Molecular Target Not applicable
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat advanced Parkinson's disease (PD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today